| Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for IPF (NCT05016817) | The Foundation for Orthopaedics and Regenerative Medicine | 2022-07-03 |
| Safety and Tolerability of LX101 for Inherited Retinal Dystrophy Associated With RPE65 Mutations (NCT06196827) | Innostellar Biotherapeutics Co.,Ltd | 2022-07-02 |
| Phase 1 Evaluation of H1 Influenza Vaccine Delivered by MIMIX MAP (NCT06125717) | Terrestrial Bio, Inc. | 2022-07-02 |
| MW151 and Whole-brain Radiotherapy in Patients With Intracranial Metastases (NCT05417282) | ImmunoChem Therapeutics, LLC | 2022-07-01 |
| Effects of Psilocybin in Post-Treatment Lyme Disease (NCT05305105) | Johns Hopkins University | 2022-07-01 |
| A Pilot Study of Neoadjuvant Chemotherapy With or Without Camrelizumab for Locally Advanced Gastric Cancer (NCT05101616) | Shanghai Minimally Invasive Surgery Center | 2022-07-01 |
| Efficacy and Safety of TMZ Plus 6-MP in the Patients With Recurrent Glioblastoma (NCT06279767) | The First Affiliated Hospital with Nanjing Medical University | 2022-07-01 |
| Comparing the Efficacy of Nitazoxanide Versus Rifaximin in Adult Patients With Irritable Bowel Syndrome Without Constipation (NCT05453916) | Sadat City University | 2022-07-01 |
| Prevention of Age-associated Cardiac and Vascular Dysfunction Using Avmacol ES (NCT05408559) | Texas Tech University Health Sciences Center | 2022-07-01 |
| Neoadj Admin Autologous Tumor Infiltrating Lymphocytes & Pembrolizumab for Treatment of Adv Melanoma Patients (NCT05176470) | Richard Wu | 2022-07-01 |
| Acalabrutinib and Duvelisib for the Treatment of Relapsed/Refractory Indolent Non-Hodgkin Lymphoma (NCT04836832) | Narendranath Epperla | 2022-07-01 |
| Development of a Digital Tool, MyInspiration, for the Improvement of Spiritual Well-Being in Patients with Cancer (NCT05198089) | Ohio State University Comprehensive Cancer Center | 2022-07-01 |
| Pharmacokinetic Study of a Novel Lipid Formulation of Cannabidiol Compared to a Standard Formulation (NCT05032807) | King's College London | 2022-07-01 |
| Immunomodulation Using VB-201 to Reduce Arterial Inflammation in Treated HIV - VITAL HIV Trial (NCT04939311) | Priscilla Hsue, MD | 2022-07-01 |
| Booster Dose Study to Assess the Safety and Immunogenicity of ACM-001 Administered Intramuscularly or Intranasally. (NCT05385991) | ACM Biolabs | 2022-07-01 |
| Study of TACE Combined With Lenvatinib to Prevent Postoperative Recurrence in Patients With MVI Positive HCC (NCT04911959) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2022-07-01 |
| Efficacy and Safety of Venetoclax Combined With Dexamethasone and Etoposide in HLH (NCT05546060) | Beijing Friendship Hospital | 2022-07-01 |
| Afuresertib +Sintilimab+Chemotherapy in Patients With Selected Solid Tumors That Resistance to Prior Anti-PD-1/PD-L1 (NCT05383482) | Laekna Limited | 2022-07-01 |
| Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamic Characteristics of HHT120 in Healthy Subjects (NCT05414734) | Shanghai Synergy Pharmaceutical Sciences Co., Ltd. | 2022-07-01 |
| CD7 CAR-T Cell Treatment of Relapsed/Refractory CD7+ T -Acute Lymphoblastic Leukemia/ Lymphoma (NCT05212584) | iCell Gene Therapeutics | 2022-07-01 |
| The Effects of Empagliflozin on Renal Outcomes in Post Severe Acute Kidney Injury Survivors (NCT05360615) | Chulalongkorn University | 2022-07-01 |
| A Single and Multiple Dose Study of Dotinurad in Chinese Healthy Participants (NCT05278676) | Eisai Co., Ltd. | 2022-07-01 |
| Brain Small Chain Fatty Acid Metabolism in Parkinson Disease: Tributyrin Supplementation (NCT05446168) | Nicolaas Bohnen, MD, PhD | 2022-07-01 |
| Clinical and Biochemical Assessment of Ozonated Olive Oil Mixed Bone Substitute in Treating Intra Bony Periodontal Defect (NCT05655923) | Ain Shams University | 2022-07-01 |
| Safety, Reactogenicity, and Immunogenicity Study of a Lyophilized COVID-19 mRNA Vaccine (NCT05366296) | Wuhan Recogen Biotechnology Co., Ltd. | 2022-07-01 |
| A Pilot Study of SurVaxM in Children Progressive or Relapsed Medulloblastoma, High Grade Glioma, Ependymoma and Newly Diagnosed Diffuse Intrinsic Pontine Glioma (NCT04978727) | Children's Oncology Group | 2022-07-01 |
| Finding Solutions to Thrive After Birth Asphyxia in Africa (NCT05275725) | Pia Wintermark | 2022-07-01 |
| Chidamide in Combination With Abemaciclib and Endocrinotherapy（Doctor's Choice） in Breast Cancer Patients Previously Treated With Palbociclib (NCT05464173) | Biyun Wang, MD | 2022-07-01 |
| A Phase 1b Trial to Evaluate the Safety and Immunogenicity of a SARS-CoV-2 mRNA Chimera Vaccine Against COVID-19 (NCT05396573) | Walvax Biotechnology Co., Ltd. | 2022-07-01 |
| Programmed Allogeneic CRISPR-edited T Cells Engineered to Express Anti-CD19 Chimeric Antigen Receptor (PACE CART19) in Patients With Relapsed Or Refractory CD19+ Leukemia and Lymphoma (NCT05037669) | University of Pennsylvania | 2022-07-01 |
| Clinical Trial to Evaluate the Pharmacokinetic Characteristics of DW5221 and DW5221-R (NCT06147908) | Daewon Pharmaceutical Co., Ltd. | 2022-07-01 |
| A Study to Evaluate the Safety and Efficacy of VGB-R04 in Adult Hemophilia B Patients (NCT05441553) | Shanghai Vitalgen BioPharma Co., Ltd. | 2022-07-01 |
| Regorafenib Plus Raltitrexed as Third-line Treatment in Advanced Colorectal Cancer Patients (NCT05426811) | China Medical University, China | 2022-07-01 |
| Anti-CD33 CAR-T Cells for the Treatment of Relapsed/Refractory CD33+ Acute Myeloid Leukemia (NCT05445765) | iCell Gene Therapeutics | 2022-07-01 |
| A Study of PM8002 Plus Nab-paclitaxel as First Line Therapy for TNBC (NCT05918133) | Biotheus Inc. | 2022-07-01 |
| Bone Marrow-Derived Mesenchymal Stem Cell Therapy for Chronic Kidney Disease (NCT05362786) | LaTonya J. Hickson | 2022-07-01 |
| Elpipodect (MK-8189) Safety and Tolerability in Participants With Alzheimer's Disease With or Without Symptoms of Agitation-Aggression and/or Psychosis (MK-8189-017) (NCT05227118) | Merck Sharp & Dohme LLC | 2022-07-01 |
| Bioequivalence Study of Empagliflozin And Linagliptin Tablets in Healthy Chinese Subjects (NCT05956522) | The Affiliated Hospital of Qingdao University | 2022-07-01 |
| Azacitidine-CHOP for Patients With Nodal T-cell Lymphoma With T-follicular Helper Phenotype (ACANTUS) (NCT05230680) | Won Seog Kim | 2022-07-01 |
| Percutaneous Inferior Cervical Sympathetic Block for Treatment of Refractory Ventricular Tachycardia (NCT04770051) | University of Missouri-Columbia | 2022-07-01 |
| Non-inferiority Trial of Locally Manufactured Typhoid Conjugate Vaccine 'Typhocon' in Bangladesh (NCT05475379) | International Centre for Diarrhoeal Disease Research, Bangladesh | 2022-07-01 |
| Dose Escalation for SBRT of Recurrent VT Ventricular Tachyarrhythmia - a Single Center, Phase II Clinical Trial (NCT05594368) | University of Zurich | 2022-07-01 |
| Study of C-TIL052A Cell Therapy in Advanced Cervical Cancer (NCT05475847) | Fudan University | 2022-07-01 |
| Effectiveness and Safety of Therapy Based on Attenuated ATO Plus Low-Dose ATRA in Patients With APL (NCT05497310) | Hospital Universitario Dr. Jose E. Gonzalez | 2022-07-01 |
| MANATEE-T1D: Metformin ANd AutomaTEd Insulin Delivery System Effects on Renal Vascular Resistance, Insulin Sensitivity, and Cardiometabolic Function in Youth With Type 1 Diabetes (NCT05065372) | Kalie Tommerdahl | 2022-07-01 |
| Pharmacokinetics and Point of Care Testing of Direct Oral Anticoagulants Subjects (NCT05491460) | Doasense GmbH | 2022-07-01 |
| A Relative Bioavailability Study Evaluating Two New Encorafenib Formulations (NCT05446142) | Pfizer | 2022-07-01 |
| A Study of BN102 in Patients With Previously Treated CLL/SLL and B-cell NHL (NCT05365100) | BioNova Pharmaceuticals (Shanghai) LTD. | 2022-07-01 |
| A Phase 1, Drug-Drug Interaction Study of TBAJ-876 in Healthy Adults (NCT05526911) | Global Alliance for TB Drug Development | 2022-06-30 |
| Genetically Engineered Cells (Anti-CD19/CD20/CD22 CAR T-cells) for the Treatment of Relapsed or Refractory Lymphoid Malignancies (NCT05418088) | Sumithira Vasu | 2022-06-30 |
| A Study to Evaluate the Safety, Tolerability and Pharmacokinetics Pharmacodynamics of SHR-2010 by Intravenously/Subcutaneously in Healthy Subject (NCT05398510) | Guangdong Hengrui Pharmaceutical Co., Ltd | 2022-06-30 |
| Comparison of Dexmedetomidine and Midazolam for Intra-op Sedation in TIVA in Children Undergoing Inguinal Hernia Repair (NCT05337085) | Sheikh Zayed Medical College | 2022-06-30 |
| A Single Ascending Dose Study to Evaluate MDK-703 in Healthy Adult Volunteers (NCT05366634) | Medikine, Inc. | 2022-06-30 |
| A Study of MRG003 in the Treatment of Patients With EGFR-positive Advanced or Metastatic Solid Tumors (NCT05688605) | Shanghai Miracogen Inc. | 2022-06-30 |
| Evaluate the Safety and Tolerability of a Single-dose Administration of BMI2004 Inj. (NCT05922813) | BMI Korea | 2022-06-30 |
| Safety and Pharmacokinetics Evaluation of Fostemsavir + (OBT) in HIV-1 Infected Children and Adolescents Who Are Failing Their cART and Have Dual- or Triple-class Antiretroviral Resistance (NCT04648280) | PENTA Foundation | 2022-06-30 |
| A Study to Assess the Effect of AZD5462 on the Pharmacokinetics of Midazolam, Rosuvastatin and Digoxin (NCT05395117) | AstraZeneca | 2022-06-30 |
| A Study to Evaluate the Safety, Tolerance, PK and PD Parameters of GZR33 and GZR101 in Healthy Male Adult Subjects (NCT06548932) | Gan and Lee Pharmaceuticals, USA | 2022-06-30 |
| CAR20.19.22 T-cells in Relapsed, Refractory B-cell Malignancies (NCT05094206) | Medical College of Wisconsin | 2022-06-30 |
| Study of V117957 in Overactive Bladder Syndrome (NCT06024642) | Imbrium Therapeutics | 2022-06-30 |
| OPC-61815 in Healthy Chinese Male Subjects (NCT05439148) | Otsuka Beijing Research Institute | 2022-06-30 |
| Mass Balance and Biotransformation Study of [14C]LXI-15028 in Humans (NCT05883306) | Shandong Luoxin Pharmaceutical Group Stock Co., Ltd. | 2022-06-30 |
| Treating Heart Failure With hiPSC-CMs (NCT05223894) | HELP Therapeutics Co., Ltd. | 2022-06-30 |
| ALLEVIATE-HF-HD Study (NCT05501652) | Alleviant Medical, Inc. | 2022-06-30 |
| Study of Furmonertinib in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) With Activating, Including Uncommon, Epidermal Growth Factor Receptor (EGFR) or Human Epidermal Growth Factor Receptor 2 (HER2) Mutations (NCT05364073) | ArriVent BioPharma, Inc. | 2022-06-30 |
| A Study of Linperlisib Combination With Camrelizumab in Patients With Solid Tumor (NCT05429398) | Shanghai YingLi Pharmaceutical Co. Ltd. | 2022-06-30 |
| A Study to Assess Safety, Tolerability, and Pharmacokinetics of ABSK061 in Patients With Advanced Solid Tumors (NCT05244551) | Abbisko Therapeutics Co, Ltd | 2022-06-30 |
| Digital Fall Prevention Study (NCT05432674) | Brigham and Women's Hospital | 2022-06-30 |
| Study to Evaluate 5-ALA Combined With CV01 Delivery of Ultrasound in Recurrent High Grade Glioma (NCT05362409) | Alpheus Medical, Inc. | 2022-06-29 |
| A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of HCP1904 in Healthy Male Volunteers. (NCT05407220) | Hanmi Pharmaceutical Company Limited | 2022-06-29 |
| Oral Azacitidine for the Treatment of Relapsed or Refractory T-cell Large Granular Lymphocytic Leukemia (NCT05141682) | Jonathan Brammer | 2022-06-29 |
| AVT03 With Prolia in Healthy Male Subjects (NCT05126784) | Alvotech Swiss AG | 2022-06-29 |
| Safety and Pharmacokinetics of Tucatinib (MK-7119) in Chinese Participants With Cancer (MK-7119-002) (NCT05382364) | Pfizer | 2022-06-29 |
| Camu-Camu Prebiotic and Immune Checkpoint Inhibition in Patients With Non-small Cell Lung Cancer and Melanoma (NCT05303493) | Centre hospitalier de l'Université de Montréal (CHUM) | 2022-06-29 |
| A Study to Evaluate Molnupiravir (MK-4482; MOV) in Participants With Severe Renal Impairment (MK-4482-003) (NCT05386758) | Merck Sharp & Dohme LLC | 2022-06-29 |
| Study of ARO-RAGE in Healthy Subjects and Patients With Inflammatory Lung Disease (NCT05276570) | Arrowhead Pharmaceuticals | 2022-06-29 |
| A Phase Ib/II Study of Recombinant Anti-IL-1β Humanized Monoclonal Antibody Injection in Chinese Participants With Acute Gout (NCT05588908) | Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. | 2022-06-29 |
| Safety, Tolerability and Pharmacokinetics of EB-203 Eye Drops in Healthy Volunteers (NCT05538949) | EyebioKorea, Inc. | 2022-06-29 |
| Copanlisib and Venetoclax for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma (NCT04939272) | City of Hope Medical Center | 2022-06-29 |
| Cyclophosphamide and Dexamethasone for the Treatment of Metastatic Castration Resistant Prostate Cancer (NCT05479578) | Rashmi Verma, MD | 2022-06-29 |
| Phase 1/2 Study Evaluating Safety and Potential Efficacy of Allocetra-OTS Via Pressurized Intra-Peritoneal Aerosol Chemotherapy as Add-on to Standard of Care Chemotherapy for Treatment of Peritoneal Metastasis (NCT05431907) | Enlivex Therapeutics RDO Ltd. | 2022-06-29 |
| A Study of GZR18 Injection in Chinese Adult Patients With Type 2 Diabetes Mellitus (T2DM) (NCT06256523) | Gan and Lee Pharmaceuticals, USA | 2022-06-29 |
| Safety and Pharmacokinetic Study of Subcutaneous ALXN1720 in Participants With Proteinuria (NCT05314231) | Alexion Pharmaceuticals, Inc. | 2022-06-29 |
| A Dose Escalation and Expansion Study of TAC-001 in Patients With Select Advanced or Metastatic Solid Tumors (NCT05399654) | Tallac Therapeutics | 2022-06-28 |
| A Study of exoASO-STAT6 (CDK-004) in Patients With Advanced Hepatocellular Carcinoma (HCC) and Patients With Liver Metastases From EIther Primary Gastric Cancer or Colorectal Cancer (CRC) (NCT05375604) | Codiak BioSciences | 2022-06-28 |
| A Study of GRC 54276 in Participants With Advanced Solid Tumors and Lymphomas. (NCT05878691) | Glenmark Specialty S.A. | 2022-06-28 |
| Effect of Repeated Oral Doses of Avacopan on the Pharmacokinetics (PK) of a Single Dose of Simvastatin (NCT06207682) | Amgen | 2022-06-28 |
| OA Optimization Program Pilot Trial (NCT05389371) | University of Calgary | 2022-06-28 |
| Ofatumumab in AQP4-IgG Seropositive NMOSD (NCT05504694) | Tang-Du Hospital | 2022-06-28 |
| A Safety Study of LY3462817 in Healthy Japanese and Non-Japanese Participants (NCT05440136) | Eli Lilly and Company | 2022-06-28 |
| A Study of Monepantel in Individuals With Motor Neurone Disease (NCT04894240) | Neurizon Therapeutics Limited | 2022-06-28 |
| A First-in-Human Study Evaluating AGA2118 in Men and Postmenopausal Women (NCT05225857) | Angitia Biopharmaceuticals | 2022-06-28 |
| Safety, Tolerability and Immunogenicity of Alveavax-v1.2, a BA.2/Omicron-optimized, DNA Vaccine for COVID-19 Prevention (NCT05844202) | Alvea Holdings, LLC | 2022-06-27 |
| Shockwave Therapy and Platelet Rich Plasma for the Treatment of Erectile Dysfunction (NCT05048667) | University of Miami | 2022-06-27 |
| Study of ARO-MUC5AC in Healthy Subjects and Patients With Muco-Obstructive Lung Disease (NCT05292950) | Arrowhead Pharmaceuticals | 2022-06-27 |
| A Study of JNJ-63733657 in Healthy Chinese Participants (NCT05407818) | Janssen Research & Development, LLC | 2022-06-27 |
| Safety and Immunogenicity of BPL-1357, A BPL-Inactivated, Whole-Virus, Universal Influenza Vaccine (NCT05027932) | National Institute of Allergy and Infectious Diseases (NIAID) | 2022-06-27 |
| Single Dose Oral Bioequivalence Study of Vortioxetine Hemihydrobromide Orally Disintegrating Tablets (NCT05417087) | Seasons Biotechnology (Taizhou) Co., Ltd. | 2022-06-27 |
| A Phase I, First in Human Study of CBA-1535, T Cell Engager(5T4/CD3/5T4) in Patients With Advanced Solid Tumors. (NCT07016997) | Chiome Bioscience Inc. | 2022-06-27 |
| Evaluation of the Immunopharmacology of EDP1815 and EDP2939 (NCT05682222) | Evelo Biosciences, Inc. | 2022-06-27 |